Essex Bank
Source: SEC Form 13F · as of Mar 2026Essex Bank holds 18 biotech & pharma companies tracked by BioSniper, totaling $39.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$39.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 68,230 | $16.7M |
| LLYELI LILLY & Co | 10,421 | $9.6M |
| MRKMerck & Co., Inc. | 28,281 | $3.4M |
| ABBVAbbVie Inc. | 13,638 | $3.0M |
| AMGNAMGEN INC | 2,556 | $899K |
| BMYBRISTOL MYERS SQUIBB CO | 13,837 | $839K |
| NVSNovartis AG | 4,814 | $735K |
| PFEPFIZER INC | 23,625 | $663K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,295 | $621K |
| AZNASTRAZENECA PLC | 2,616 | $516K |
| PMPhilip Morris International Inc | 3,068 | $507K |
| GILDGILEAD SCIENCES, INC. | 3,588 | $500K |
| ABTABBOTT LABORATORIES | 4,572 | $469K |
| NVONovo Nordisk A/S | 9,758 | $359K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 626 | $280K |
| CORCencora Inc. | 816 | $256K |
| MCKMcKesson Corporation | 254 | $220K |
| REGNREGENERON PHARMACEUTICALS, INC. | 282 | $218K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.